Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)
Close on Nov 17, 2026Market cap $150.87MP/E –Yield –
Inogen cash
Cash and short-term investments held at the end of each period.
Inogen's cash was $105.54M at Jun 30, 2026. For fiscal 2025 it was $119.58M, up 5.1% from the year before. Over ten years it grew 3.7% a year on average. The highest annual figure on record is $245.51M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $119.58M | +5.1% |
| FY2024 | Dec 31, 2024 | $113.80M | -11.4% |
| FY2023 | Dec 31, 2023 | $128.47M | -31.3% |
| FY2022 | Dec 31, 2022 | $187.01M | -23.8% |
| FY2021 | Dec 31, 2021 | $245.51M | +6.2% |
| FY2020 | Dec 31, 2020 | $231.22M | +10.6% |
| FY2019 | Dec 31, 2019 | $209.09M | -13.0% |
| FY2018 | Dec 31, 2018 | $240.35M | +38.2% |
| FY2017 | Dec 31, 2017 | $173.94M | +52.7% |
| FY2016 | Dec 31, 2016 | $113.88M | +37.4% |
| FY2015 | Dec 31, 2015 | $82.90M | +45.9% |
| FY2014 | Dec 31, 2014 | $56.84M | +320.4% |
| FY2013 | Dec 31, 2013 | $13.52M | -10.5% |
| FY2012 | Dec 31, 2012 | $15.11M | +286.9% |
| FY2011 | Dec 31, 2011 | $3.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $105.54M | -13.8% |
| Q1 FY2026 | Mar 31, 2026 | $110.17M | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $119.58M | +5.1% |
| Q3 FY2025 | Sep 30, 2025 | $123.22M | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | $122.43M | +4.0% |
| Q1 FY2025 | Mar 31, 2025 | $118.89M | -0.8% |
| Q4 FY2024 | Dec 31, 2024 | $113.80M | -11.4% |
| Q3 FY2024 | Sep 30, 2024 | $120.66M | -12.6% |
| Q2 FY2024 | Jun 30, 2024 | $117.69M | -30.8% |
| Q1 FY2024 | Mar 31, 2024 | $119.81M | -31.4% |
| Q4 FY2023 | Dec 31, 2023 | $128.47M | -31.3% |
| Q3 FY2023 | Sep 30, 2023 | $138.04M | -34.2% |
| Q2 FY2023 | Jun 30, 2023 | $170.15M | -23.9% |
| Q1 FY2023 | Mar 31, 2023 | $174.57M | -21.9% |
| Q4 FY2022 | Dec 31, 2022 | $187.01M | -23.8% |
| Q3 FY2022 | Sep 30, 2022 | $209.63M | -14.5% |
| Q2 FY2022 | Jun 30, 2022 | $223.62M | -10.5% |
| Q1 FY2022 | Mar 31, 2022 | $223.39M | -4.2% |
| Q4 FY2021 | Dec 31, 2021 | $245.51M | +6.2% |
| Q3 FY2021 | Sep 30, 2021 | $245.13M | +11.2% |
| Q2 FY2021 | Jun 30, 2021 | $249.96M | +14.3% |
| Q1 FY2021 | Mar 31, 2021 | $233.15M | +11.9% |
| Q4 FY2020 | Dec 31, 2020 | $231.22M | +10.6% |
| Q3 FY2020 | Sep 30, 2020 | $220.51M | +9.9% |
| Q2 FY2020 | Jun 30, 2020 | $218.64M | -14.6% |
| Q1 FY2020 | Mar 31, 2020 | $208.36M | -12.9% |
| Q4 FY2019 | Dec 31, 2019 | $209.09M | -13.0% |
| Q3 FY2019 | Sep 30, 2019 | $200.65M | -10.4% |
| Q2 FY2019 | Jun 30, 2019 | $256.15M | +22.9% |
| Q1 FY2019 | Mar 31, 2019 | $239.25M | +27.1% |
| Q4 FY2018 | Dec 31, 2018 | $240.35M | +38.2% |
| Q3 FY2018 | Sep 30, 2018 | $223.86M | +37.3% |
| Q2 FY2018 | Jun 30, 2018 | $208.41M | +44.5% |
| Q1 FY2018 | Mar 31, 2018 | $188.30M | +46.8% |
| Q4 FY2017 | Dec 31, 2017 | $173.94M | +52.7% |
| Q3 FY2017 | Sep 30, 2017 | $163.09M | +50.5% |
| Q2 FY2017 | Jun 30, 2017 | $144.21M | – |
| Q1 FY2017 | Mar 31, 2017 | $128.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $113.88M | – |
| Q3 FY2016 | Sep 30, 2016 | $108.34M | – |
See a number that looks wrong?